Research for Innovative Care

Emotional Pain

The Science of Pain and Addiction: Neurobiology, Neuroplasticity, and Ethics at the Bedside

Brent E Boyett, DMD, DO, DFASAM

Healing or Harming? The Biochemical Consequences of Controlled Substance Medications

Brent E Boyett, DMD, DO, DFASAM

Beta-Arrestin-Mediated Downregulation of μ-Opioid and Dopamine Receptors: Implications for Tolerance, Opioid-Induced Hyperalgesia, and the Opponent Process in Addiction

Grace Willoughby, DO

Benzodiazepine-Induced Receptor Alterations and the Rebound Effect: A Neuroadaptive Model Aligned with Opponent Process Theory

Mackenzie Reilly, DO

Clinical Policy: Management of Patients on Controlled Substances under Treatment Agreement

Brent E Boyett, DMD, DO, DFASAM

Understanding Acute and Chronic Pain: What You Need to Know

Brent E Boyett, DMD, DO, DFASAM

ASAM Clinical Pearls; Dr. Boyett discusses the use of ketamine in the treatment of addiction with the president of American Society of Addiction Medicine.

Brent E Boyett, DMD, DO, DFASAM

Cannabinology; The Science of Cannabis

Brent E Boyett, DMD, DO, DFASAM

The Ketamine Revolution

Brent E Boyett, DMD, DO, DFASAM

Breaking Patterns; Chapter 2: Preparing for the Ketamine Experience

Brent E Boyett, DMD, DO, DFASAM